BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27193073)

  • 21. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of Quantitative EEG to the Diagnosis of Early Cognitive Impairment in Patients With Idiopathic Parkinson's Disease.
    Guner D; Tiftikcioglu BI; Tuncay N; Zorlu Y
    Clin EEG Neurosci; 2017 Sep; 48(5):348-354. PubMed ID: 27491643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.
    Lillig R; Ophey A; Schulz JB; Reetz K; Wojtala J; Storch A; Liepelt-Scarfone I; Becker S; Berg D; Balzer-Geldsetzer M; Kassubek J; Hilker-Roggendorf R; Witt K; Mollenhauer B; Trenkwalder C; Roeske S; Wittchen HU; Riedel O; Dodel R; Kalbe E
    Parkinsonism Relat Disord; 2021 Sep; 90():90-97. PubMed ID: 34418761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis.
    Higginson CI; Wheelock VL; Carroll KE; Sigvardt KA
    J Clin Exp Neuropsychol; 2005 May; 27(4):516-28. PubMed ID: 15962695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex Differences in Cognitive Changes in De Novo Parkinson's Disease.
    Bayram E; Banks SJ; Shan G; Kaplan N; Caldwell JZK
    J Int Neuropsychol Soc; 2020 Feb; 26(2):241-249. PubMed ID: 31822306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
    Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
    Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
    Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
    Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients.
    Lehrner J; Moser D; Klug S; Gleiß A; Auff E; Pirker W; Pusswald G
    Eur J Neurol; 2014 Oct; 21(10):1276-84, e77. PubMed ID: 24909761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease.
    van de Weijer SC; Duits AA; Bloem BR; Kessels RP; Jansen JF; Köhler S; Tissingh G; Kuijf ML
    BMC Neurol; 2016 Nov; 16(1):209. PubMed ID: 27809791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A parsimonious scoring and normative calculator for the Parkinson's disease mild cognitive impairment battery.
    Bezdicek O; Sulc Z; Nikolai T; Stepankova H; Kopecek M; Jech R; Růžička E
    Clin Neuropsychol; 2017; 31(6-7):1231-1247. PubMed ID: 28276860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dementia and mild cognitive impairment in Parkinson's disease: a review].
    Bocanegra Y; Trujillo-Orrego N; Pineda D
    Rev Neurol; 2014 Dec; 59(12):555-69. PubMed ID: 25501454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of Cognitive Performance Based on Premorbid Intelligence in Parkinson's Disease.
    Del Pino R; Díez-Cirarda M; Peña J; Ibarretxe-Bilbao N; Ojeda N
    J Parkinsons Dis; 2020; 10(4):1717-1725. PubMed ID: 32925100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.
    Kawabata K; Watanabe H; Hara K; Bagarinao E; Yoneyama N; Ogura A; Imai K; Masuda M; Yokoi T; Ohdake R; Tanaka Y; Tsuboi T; Nakamura T; Hirayama M; Ito M; Atsuta N; Maesawa S; Naganawa S; Katsuno M; Sobue G
    J Neurol; 2018 Mar; 265(3):688-700. PubMed ID: 29392456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.